Faster global financial news!
AstraZeneca acquires global rights to lung cancer treatment Zegfrovy from Dizal Pharmaceutical for $600 million upfront, with potential for up to $1.5 billion
svmuu.com23/08/2026 15:58
Complaint Report
Complaint Report
AstraZeneca will pay Dizal Pharmaceutical Co., Ltd. an initial $600 million, with an additional $900 million contingent on development, regulatory, and sales milestones. Zegfrovy (sunvozertinib) is an oral treatment for non-small cell lung cancer with specific EGFR mutations, already approved in the United States and China. AstraZeneca will assume responsibility for its global development and commercialization.
Source：Yahoo财经 · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
Previous: Analysis indicates that the Fidelity MSCI Health Care Index ETF (FHLC) has lower fees and is more diversified, while the Invesco Pharmaceuticals ETF (PJP) has shown higher returns in recent years but carries concentrated risk.
|
Next: Elon Musk reposts a discussion on Milton Friedman's 'broken window fallacy,' highlighting it as the 'oldest mistake in economics' that governments still make.
24H Trending
-
1
Gate.io Platform Analysis: Global Operations and Mobile Application Features
-
2
Who is the founder of EGLD coin? An analysis of MultiversX token purchase channels
-
3
FXN Token: Solana vs. Ethereum/Arbitrum Version Purchase and Trading Guide
-
4
NAMI Coin Value and Investment Analysis: Multi-Project Differentiation and Risk Considerations
-
5
BEXT Coin (ByteDex) Ecosystem and Token Value Analysis
-
6
CHRO Token: Chronicum Game Token Status and Market Liquidity Analysis
-
7
ORAI Coin: An Analysis of the AI-Driven Blockchain and Oracle Project and Its Recent Challenges
-
8
MONES (MONES) Token Status Analysis: Market Activity and Trading Channels
-
9
CKB Coin Analysis: Nervos Network's Native Token and Its Ecosystem Outlook
-
10
DSP Token Analysis: Trading and Listing Platforms for Delio DSP and Deepswap Protocol
Markets Today
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
- User Agreement
- Privacy Policy
- Contact Us
- Business Partnerships
- Disclaimer
- Content Statement
- About Us
- Sitemap
Coming Soon!
